Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva

Isabel M Ott et al. Emerg Infect Dis. 2021 Apr.

Abstract

The expense of saliva collection devices designed to stabilize severe acute respiratory syndrome coronavirus 2 RNA is prohibitive to mass testing. However, virus RNA in nonsupplemented saliva is stable for extended periods and at elevated temperatures. Simple plastic tubes for saliva collection will make large-scale testing and continued surveillance easier.

Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; coronavirus disease; diagnostics; respiratory infections; saliva; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA (N1) detection in saliva. A) Detection of SARS-CoV-2 RNA in 20 saliva samples on day of sample collection (fresh) did not significantly change after storage at −80°C (to assess the effect of a freeze/thaw cycle), 3 days at 30°C, or 5 days at RT (recorded as ≈19°C). Detection of N1 remained similar to that of freshly collected samples, regardless of starting Ct value (Pearson r = −0.085, p = 0.518). B) At RT, detection remained stable for up to 25 days. Colored dashed lines track the same sample through different storage conditions. Black horizontal dashed lines represent Ct 38, which we applied as the cutoff to determine sample positivity. Samples that remained not detected after 45 cycles are depicted on the x-axis. Ct, cycle threshold; RT, room temperature.
Figure 2
Figure 2
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in saliva samples tested for infectious SARS-CoV-2. SARS-CoV-2 N1 detection (Ct values) measured by quantitative reverse transcription PCR for each saliva sample incubated with Vero-E6 cells for 72 hours. The orange diamond depicts the only sample that produced plaque-forming units (titer increase of 3.79 × 104 PFU/mL; purple circles indicate samples that did not produce plaque-forming units by 72 h after inoculation; dashed lines indicate Ct 38 (the cutoff for sample positivity); gray shading indicates Cts below the limit of detection. Ct, cycle threshold.

Update of

Similar articles

Cited by

References

    1. Hanson KE, Barker AP, Hillyard DR, Gilmore N, Barrett JW, Orlandi RR, et al. Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J Clin Microbiol. 2020;58:e01824–20. 10.1128/JCM.01824-20 - DOI - PMC - PubMed
    1. Byrne RL, Kay GA, Kontogianni K, Aljayyoussi G, Brown L, Collins AM, et al. Saliva alternative to upper respiratory swabs for SARS-CoV-2 diagnosis. Emerg Infect Dis. 2020;26:2770–1. 10.3201/eid2611.203283 - DOI - PMC - PubMed
    1. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med. 2020;383:1283–6. 10.1056/NEJMc2016359 - DOI - PMC - PubMed
    1. Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Sci Immunol. 2020;5:eabe5511. - PMC - PubMed
    1. Pisanic N, Randad PR, Kruczynski K, Manabe YC, Thomas DL, Pekosz A, et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J Clin Microbiol. 2020;59:e02204–20. 10.1128/JCM.02204-20 - DOI - PMC - PubMed

Publication types